Evaluation of pharmacokinetics and safety profiles between S-1 granule and S-1 capsule in patients with solid tumors

被引：0
|
作者：
Takahashi, T. [1 ]
Hironaka, S. [2 ]
Yasui, H. [2 ]
Endo, M. [3 ]
Nakamura, Y. [1 ]
Yamamoto, N. [1 ]
Boku, N. [2 ]
机构：
[1] Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan
[2] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan
[3] Shizuoka Canc Ctr, Div Endoscope, Shizuoka, Japan
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)70463-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：136 / 136
页数：1
相关论文
共 50 条
  • [31] Comparison of the Pharmacokinetics of S-1, an Oral Anticancer Agent, in Western and Japanese Patients
    Emmanuelle Comets
    Kazumasa Ikeda
    Paulo Hoff
    Pierre Fumoleau
    Jantien Wanders
    Yusuke Tanigawara
    Journal of Pharmacokinetics and Pharmacodynamics, 2003, 30 : 257 - 283
  • [32] A phase I study with S-1, an oral 5-FU formulation, in patients with solid tumors
    VanGroeningen, CJ
    Schornagel, JH
    Peters, GJ
    Noordhuis, P
    VanKuilenburg, ABP
    Shirasaka, T
    Shimamura, Y
    deVries, MJ
    Hanauske, AR
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1104 - 1104
  • [33] Oral S-1 With Concurrent Radiotherapy Versus S-1 Alone in Patients With Locally Unresectable Pancreatic Cancer
    Shinchi, H.
    Takao, S.
    Maemura, K.
    Mataki, Y.
    Kurahara, H.
    Hiwatashi, K.
    Ino, S.
    Sakoda, M.
    Ueno, S.
    Natsugoe, S.
    PANCREAS, 2014, 43 (08) : 1407 - 1407
  • [34] Effect of S-1 on pharmacokinetics of irinotecan in a patient with colorectal cancer
    Yokoo, Koji
    Watanabe, Hiroshi
    Hamada, Akinobu
    Masa, Kengo
    Saito, Hideyuki
    Terazaki, Hisayasu
    Sasaki, Yutaka
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 80 (04) : 422 - 424
  • [35] Response to "The Unanswered Question: What Is the Determinant of S-1 Pharmacokinetics?"
    Kaida, Y.
    Inui, N.
    Suda, T.
    Watanabe, H.
    Chida, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (02) : 204 - 204
  • [36] SPLITTING OF S-1(3) AND S-1(0) STATES IN LI6
    TAMURA, T
    PHYSICAL REVIEW, 1957, 105 (06): : 1808 - 1809
  • [37] S-1 COMBINATION CHEMOTHERAPY IS SUPERIOR TO S-1 MONOTHERAPY FOR UNRESECTABLE ADVANCED GASTRIC CANCER IN AGED PATIENTS
    Miura, Tomofumi
    Nakamura, Junichiro
    Yamada, Satoshi
    Nakazawa, Yasuko
    Ozeki, Yutaka
    Miura, Tsutomu
    Yanagi, Masahiko
    Takahashi, Toru
    ANNALS OF ONCOLOGY, 2010, 21 : 28 - 28
  • [38] ON THE OPTIMALITY OF THE (S-1,S) POLICY
    SCHULTZ, CR
    NAVAL RESEARCH LOGISTICS, 1990, 37 (05) : 715 - 723
  • [39] FREE S-1 ACTIONS
    STONG, RE
    MATHEMATISCHE ANNALEN, 1977, 226 (02) : 151 - 153
  • [40] Detecting S-1 radiculopathy
    Stewart, C
    PHYSICIAN AND SPORTSMEDICINE, 1997, 25 (02): : 25 - 25
12345